Your browser doesn't support javascript.
loading
Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Adeowo, Fatima Y; Oyetunji, Tosin P; Ejalonibu, Murtala A; Ndagi, Umar; Kumalo, Hezekiel M; Lawal, Monsurat M.
Affiliation
  • Adeowo FY; Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa.
  • Oyetunji TP; Faculty of Public Health, University of Ibadan, Nigeria.
  • Ejalonibu MA; Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa.
  • Ndagi U; Center for Trans-Sahara Disease, Vaccine and Drug Research, IBB University Lapai, Niger State, Minna, Nigeria.
  • Kumalo HM; Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa.
  • Lawal MM; Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa.
Chem Biodivers ; 18(11): e2100361, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34547176

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylcholinesterase / Butyrylcholinesterase / Cholinesterase Inhibitors / Neuroprotective Agents / Alzheimer Disease / Rivastigmine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Chem Biodivers Journal subject: BIOQUIMICA / QUIMICA Year: 2021 Type: Article Affiliation country: South Africa

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylcholinesterase / Butyrylcholinesterase / Cholinesterase Inhibitors / Neuroprotective Agents / Alzheimer Disease / Rivastigmine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Chem Biodivers Journal subject: BIOQUIMICA / QUIMICA Year: 2021 Type: Article Affiliation country: South Africa